Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intrave… recall — Class I (D-0015-2026) · pharmaranks
Class IOngoing
Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use recall
FDA recall D-0015-2026 · initiated Sep 16, 2025
Most serious — a reasonable probability that use will cause serious harm or death.
Why it was recalled
Subpotent Drug: Testing revealed there was no oxytocin in the IV bag.
Details
Product
Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use, Rx only, IntegraDose Compounding Services LLC, 719 Kasota Ave Se, Minneapolis, MN 55414-2842 NDC 71139-0012-1
Recalling company
IntegraDose Compounding Services LLC
Classification
Class I
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Nationwide in the USA
Initiated
Sep 16, 2025
FDA report date
Oct 22, 2025
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.